Explore
🏠 Home ⚙️ Dashboard 🔍 Explore 📈 Funds 🏢 AMC 🏭 Companies 📊 Sectors
Tools
🎯 Goal Planner 🔄 Fund Overlap 🧮 SIP Calculator ⏳ SWP Calculator 📊 Similar Funds
Health Care

MARKSANS PHARMA LTD

Analyze mutual fund ownership, AMC exposure and portfolio concentration for MARKSANS PHARMA LTD.

21
Funds Holding
20.51%
Total Exposure

📊 Quick Summary Of This Page

MARKSANS PHARMA LTD is held by multiple mutual funds across India, making it an important institutional holding. Analyze fund ownership patterns, exposure levels and investment concentration across AMCs.
🏆
Top Mutual Fund Owners
21
Mutual funds currently holding this company.
📈
Portfolio Exposure
20.51%
Combined exposure across funds.
🏦
Participating AMCs
12
Asset management companies.
🔥 Top Funds With Highest Exposure
#1
Kotak Special Opportunities Fund - Direct Plan KOTAKMAHINDRAMF
3.08%
#2
Old Bridge Flexi Cap Fund - Direct Plan OLDBRIDGE
2.37%
#3
KotaK MNC Fund - Direct Plan KOTAKMAHINDRAMF
2.31%
#4
Kotak Healthcare Fund - Direct Plan KOTAKMAHINDRAMF
2.27%
#5
UTI Healthcare Fund - Direct Plan UTI
2.17%
#6
Unifi Flexi Cap Fund - Direct Plan UNIFI
1.94%
#7
UTI Small Cap Fund - Direct Plan UTI
1.45%
#8
JM Small Cap Fund - Direct Plan JM FINANCIAL
1.00%
#9
UTI Multi Cap Fund - Direct Plan UTI
0.84%
#10
UTI Large & Mid Cap Fund - Direct Plan UTI
0.80%
🏆 Category Exposure
Sectoral/Thematic 9.83%
Flexi Cap 4.37%
Small Cap 3.03%
Multi Cap 0.84%
Large & Mid Cap 0.80%
Aggressive 0.55%
🔗 Similar Companies
SUN PHARMACEUTICAL INDUSTRIES LTD
APOLLO HOSPITALS ENTERPRISE LTD
TORRENT PHARMACEUTICALS LTD
CIPLA LTD
DIVI''S LABORATORIES LTD
FORTIS HEALTHCARE LTD
AUROBINDO PHARMA LTD
LUPIN LTD
BIOCON LTD
GLENMARK PHARMACEUTICALS LTD
AJANTA PHARMA LTD
ALKEM LABORATORIES LTD
ZYDUS LIFESCIENCES LTD
ABBOTT INDIA LTD
DR LAL PATH LABS LTD
NEULAND LABORATORIES LTD
GLAXOSMITHKLINE PHARMACEUTICALS LTD
SYNGENE INTERNATIONAL LTD
ASTER DM QUALITY CARE LTD
ERIS LIFESCIENCES LTD
🏦 Top AMC Owners
7.66%
5.81%
2.37%
1.94%
1.00%
0.68%
0.64%
0.27%
0.07%
0.03%
📊 Ownership Insights

MARKSANS PHARMA LTD is currently held by 21 mutual funds with a combined exposure of 20.51% .

The top 10 mutual funds together account for approximately 18.22% portfolio weight in this company.

This stock is most actively owned by 12 AMCs across multiple mutual fund categories.

🚀 Continue Your Research

Compare Funds Similar Funds Historical SIP Explore Hub
🚀 Explore The Complete Mutual Fund Universe
Discover top-ranked mutual funds, compare schemes, analyze portfolio holdings, explore AMCs, identify category leaders and use powerful investment planning tools — all from one place.
⭐ Top Ranked Funds 🏆 Category Leaders 🏢 AMC Insights 📈 Popular Stocks 🛠 Planning Tools 🔍 Similar Funds
Explore CheckPAN
Browse 7,500+ mutual funds, leading AMCs, portfolio companies and investment insights.
Frequently Asked Questions

This page shows mutual funds that currently invest in MARKSANS PHARMA LTD, along with their exposure and allocation percentage.

Mutual funds invest in MARKSANS PHARMA LTD based on factors such as financial performance, growth potential, valuation and sector outlook.

Mutual fund exposure to MARKSANS PHARMA LTD represents the total percentage of holdings across all mutual fund portfolios combined.

High mutual fund holding in MARKSANS PHARMA LTD indicates institutional interest, but it should be analyzed along with fundamentals and market conditions.

Yes, mutual funds frequently adjust their holdings in MARKSANS PHARMA LTD based on market conditions and investment strategy.

Multiple AMCs may invest in MARKSANS PHARMA LTD depending on their fund strategy, sector allocation and risk profile.

MARKSANS PHARMA LTD belongs to a specific industry sector which influences its inclusion in mutual fund portfolios.

Yes, you can track changes in mutual fund holdings of MARKSANS PHARMA LTD whenever new portfolio disclosures are released.

Mutual fund ownership can influence liquidity and demand, but stock price is affected by multiple market and business factors.

You can analyze institutional investment in MARKSANS PHARMA LTD by reviewing mutual fund holdings, allocation trends and ownership concentration.
© 2026 CheckPan